Biotechnology & Life Sciences Global On demand · 24-48h

Global Transfection Reagents and Equipment Market Strategic Research Report

Global Transfection Reagents and Equipment Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Transfection Reagents and Equipment Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Reagents, Equipment

By Application: Protein Production, Gene & mRNA Expression Studies, Cell & Gene Therapy Manufacturing, Cancer Research, Drug Discovery & Screening

Key Players: Thermo Fisher Scientific Inc., Lonza Group Ltd., Merck KGaA (Millipore Sigma), Bio-Rad Laboratories Inc., Qiagen N.V., MaxCyte Inc., Mirus Bio LLC, Polyplus-transfection SA, Promega Corporation, Agilent Technologies Inc., Takara Bio Inc., Bio-Techne (R&D Systems), OriGene Technologies Inc., Integrated DNA Technologies (IDT), SignaGen Laboratories, Altogen Biosystems, Biontex Laboratories GmbH, Celetrix LLC

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 150 pages

Overview

Scope of the Report

This study of the global Transfection Reagents and Equipment market sets out how the market is defined, how it divides by type and application, and which regions and participants are expected to matter most over the 2026 to 2032 outlook.

As the title indicates, the scope brings together Transfection Reagents and Equipment. Analysis starts from a global definition of the market, then moves to segment-level outlooks by type and application, and finishes with regional and country-level forecasts.

Market Segmentation

The report breaks the Transfection Reagents and Equipment market down as follows, and each segment is sized and forecast to 2032:

  • By Product: Reagents and Equipment
  • By Method: Biochemical Methods, Physical Methods and Viral Methods
  • By Application: Protein Production, Gene & mRNA Expression Studies, Cell & Gene Therapy Manufacturing, Cancer Research and Drug Discovery & Screening
  • By Cell Type: Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells and Plant Cells
  • By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROs & CMOs

Regional analysis covers Asia Pacific, North America, Europe, the Middle East and Africa and Latin America, with country-level forecasts.

Market Context

Biotechnology and life sciences markets tend to be shaped by research funding, scientific advances, regulatory pathways and the pace of translation from lab to clinic. Suppliers of Transfection Reagents and Equipment are generally compared on engineering quality, total cost of ownership, manufacturing capacity and the strength of their distribution and service networks.

Competitive Landscape

Company coverage spans 18 participants in Transfection Reagents and Equipment, namely Thermo Fisher Scientific Inc., Lonza Group Ltd., Merck KGaA (Millipore Sigma), Bio-Rad Laboratories Inc., Qiagen N.V., MaxCyte Inc., Mirus Bio LLC, Polyplus-transfection SA, Promega Corporation, Agilent Technologies Inc., Takara Bio Inc., Bio-Techne (R&D Systems), OriGene Technologies Inc., Integrated DNA Technologies (IDT), SignaGen Laboratories, Altogen Biosystems, Biontex Laboratories GmbH and Celetrix LLC.

Profiles follow a consistent structure: overview, products and segments, financial performance, strategy, SWOT analysis and strategic implications.

What the Report Covers

Its chapters cover:

  • How the Transfection Reagents and Equipment market is defined, how large it is and how it is forecast to grow from 2026 to 2032
  • Segment outlook by type and by application
  • Regional outlook for five regions and country-level forecasts for 20 countries
  • The factors expected to push the Transfection Reagents and Equipment market forward or hold it back, with an impact assessment of each
  • Company profiles and the competitive landscape, including competitive intensity and key player strategies
  • Structural analysis using the Porter's Five Forces, PESTLE and SWOT frameworks
  • Future trends, technology and innovation, and the investment and M&A outlook

As an on-demand report, it is prepared to this scope after purchase and delivered in PDF within 24 to 48 hours.

Key Questions Answered

  • How large is the global Transfection Reagents and Equipment market today, and how is it expected to grow between 2026 and 2032?
  • What is driving demand for Transfection Reagents and Equipment, and what could slow growth?
  • Which product segments of Transfection Reagents and Equipment - Reagents and Equipment - are positioned for the strongest growth?
  • How does the Transfection Reagents and Equipment market differ by end user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROs & CMOs)?
  • How do Thermo Fisher Scientific Inc., Lonza Group Ltd. and Merck KGaA (Millipore Sigma) and the other profiled companies compare on positioning and strategy in Transfection Reagents and Equipment?
  • Which technology and innovation trends are most likely to change the Transfection Reagents and Equipment market?

Who Can Use This Report

  • Manufacturers, suppliers and component makers benchmarking their Transfection Reagents and Equipment portfolio and planning product, capacity and sourcing strategy
  • Customers, distributors and channel partners such as Protein Production, Gene & mRNA Expression Studies and Cell & Gene Therapy Manufacturing evaluating demand and sourcing options
  • Investment professionals, advisers and strategy teams looking for a structured view of opportunity and risk
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
ReagentsEquipment
By Application
Protein ProductionGene & mRNA Expression StudiesCell & Gene Therapy ManufacturingCancer ResearchDrug Discovery & Screening

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Segment Outlook by Product
  • 2.1.4 Segment Outlook by Method
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Product
  • 3.1 Market Segmentation by Product
  • 3.1.1 Market by Product Overview
  • 3.1.2 Reagents
  • 3.1.3 Equipment
04Market Segmentation by Method
  • 4.1 Market Segmentation by Method
  • 4.1.1 Market by Method Overview
  • 4.1.2 Biochemical Methods
  • 4.1.3 Physical Methods
  • 4.1.4 Viral Methods
05Market Segmentation by Application
  • 5.1 Market Segmentation by Application
  • 5.1.1 Market by Application Overview
  • 5.1.2 Protein Production
  • 5.1.3 Gene & mRNA Expression Studies
  • 5.1.4 Cell & Gene Therapy Manufacturing
  • 5.1.5 Cancer Research
  • 5.1.6 Drug Discovery & Screening
06Market Segmentation by Cell Type
  • 6.1 Market Segmentation by Cell Type
  • 6.1.1 Market by Cell Type Overview
  • 6.1.2 Mammalian Cells
  • 6.1.3 Bacterial Cells
  • 6.1.4 Yeast & Fungi
  • 6.1.5 Insect Cells
  • 6.1.6 Plant Cells
07Market Segmentation by End User
  • 7.1 Market Segmentation by End User
  • 7.1.1 Market by End User Overview
  • 7.1.2 Pharmaceutical & Biotechnology Companies
  • 7.1.3 Academic & Research Institutes
  • 7.1.4 CROs & CMOs
08Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
09Country-Level Market Forecast
  • 9.1 Asia Pacific
  • 9.1.1 China
  • 9.1.2 Japan
  • 9.1.3 India
  • 9.1.4 South Korea
  • 9.1.5 Australia
  • 9.1.6 Rest of Asia Pacific
  • 9.2 North America
  • 9.2.1 United States
  • 9.2.2 Canada
  • 9.2.3 Mexico
  • 9.2.4 Rest of North America
  • 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 United Kingdom
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
  • 9.4 Middle East & Africa
  • 9.4.1 GCC
  • 9.4.2 South Africa
  • 9.4.3 Rest of Middle East & Africa
  • 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Argentina
  • 9.5.3 Rest of Latin America
10Growth Drivers & Inhibitors
  • 10.1 Growth Drivers & Inhibitors
  • 10.1.1 Section Overview
  • 10.1.2 Growth Drivers
  • 10.1.3 Growth Inhibitors
  • 10.1.4 Driver and Inhibitor Impact Assessment
  • 10.1.5 Analyst Perspective
11Key Company Profiles
  • 11.1 Thermo Fisher Scientific Inc.
  • 11.1.1 Company Overview
  • 11.1.2 Key Products & Segments
  • 11.1.3 Financial Performance (2023–2025)
  • 11.1.4 Business Strategy
  • 11.1.5 SWOT Analysis
  • 11.1.6 Strategic Implications (2026–2032)
  • 11.2 Lonza Group Ltd.
  • 11.2.1 Company Overview
  • 11.2.2 Key Products & Segments
  • 11.2.3 Financial Performance (2023–2025)
  • 11.2.4 Business Strategy
  • 11.2.5 SWOT Analysis
  • 11.2.6 Strategic Implications (2026–2032)
  • 11.3 Merck KGaA (Millipore Sigma)
  • 11.3.1 Company Overview
  • 11.3.2 Key Products & Segments
  • 11.3.3 Financial Performance (2023–2025)
  • 11.3.4 Business Strategy
  • 11.3.5 SWOT Analysis
  • 11.3.6 Strategic Implications (2026–2032)
  • 11.4 Bio-Rad Laboratories Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Key Products & Segments
  • 11.4.3 Financial Performance (2023–2025)
  • 11.4.4 Business Strategy
  • 11.4.5 SWOT Analysis
  • 11.4.6 Strategic Implications (2026–2032)
  • 11.5 Qiagen N.V.
  • 11.5.1 Company Overview
  • 11.5.2 Key Products & Segments
  • 11.5.3 Financial Performance (2023–2025)
  • 11.5.4 Business Strategy
  • 11.5.5 SWOT Analysis
  • 11.5.6 Strategic Implications (2026–2032)
  • 11.6 MaxCyte Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Key Products & Segments
  • 11.6.3 Financial Performance (2023–2025)
  • 11.6.4 Business Strategy
  • 11.6.5 SWOT Analysis
  • 11.6.6 Strategic Implications (2026–2032)
  • 11.7 Mirus Bio LLC
  • 11.7.1 Company Overview
  • 11.7.2 Key Products & Segments
  • 11.7.3 Financial Performance (2023–2025)
  • 11.7.4 Business Strategy
  • 11.7.5 SWOT Analysis
  • 11.7.6 Strategic Implications (2026–2032)
  • 11.8 Polyplus-transfection SA
  • 11.8.1 Company Overview
  • 11.8.2 Key Products & Segments
  • 11.8.3 Financial Performance (2023–2025)
  • 11.8.4 Business Strategy
  • 11.8.5 SWOT Analysis
  • 11.8.6 Strategic Implications (2026–2032)
  • 11.9 Promega Corporation
  • 11.9.1 Company Overview
  • 11.9.2 Key Products & Segments
  • 11.9.3 Financial Performance (2023–2025)
  • 11.9.4 Business Strategy
  • 11.9.5 SWOT Analysis
  • 11.9.6 Strategic Implications (2026–2032)
  • 11.10 Agilent Technologies Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Key Products & Segments
  • 11.10.3 Financial Performance (2023–2025)
  • 11.10.4 Business Strategy
  • 11.10.5 SWOT Analysis
  • 11.10.6 Strategic Implications (2026–2032)
  • 11.11 Takara Bio Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Key Products & Segments
  • 11.11.3 Financial Performance (2023–2025)
  • 11.11.4 Business Strategy
  • 11.11.5 SWOT Analysis
  • 11.11.6 Strategic Implications (2026–2032)
  • 11.12 Bio-Techne (R&D Systems)
  • 11.12.1 Company Overview
  • 11.12.2 Key Products & Segments
  • 11.12.3 Financial Performance (2023–2025)
  • 11.12.4 Business Strategy
  • 11.12.5 SWOT Analysis
  • 11.12.6 Strategic Implications (2026–2032)
  • 11.13 OriGene Technologies Inc.
  • 11.13.1 Company Overview
  • 11.13.2 Key Products & Segments
  • 11.13.3 Financial Performance (2023–2025)
  • 11.13.4 Business Strategy
  • 11.13.5 SWOT Analysis
  • 11.13.6 Strategic Implications (2026–2032)
  • 11.14 Integrated DNA Technologies (IDT)
  • 11.14.1 Company Overview
  • 11.14.2 Key Products & Segments
  • 11.14.3 Financial Performance (2023–2025)
  • 11.14.4 Business Strategy
  • 11.14.5 SWOT Analysis
  • 11.14.6 Strategic Implications (2026–2032)
  • 11.15 SignaGen Laboratories
  • 11.15.1 Company Overview
  • 11.15.2 Key Products & Segments
  • 11.15.3 Financial Performance (2023–2025)
  • 11.15.4 Business Strategy
  • 11.15.5 SWOT Analysis
  • 11.15.6 Strategic Implications (2026–2032)
  • 11.16 Altogen Biosystems
  • 11.16.1 Company Overview
  • 11.16.2 Key Products & Segments
  • 11.16.3 Financial Performance (2023–2025)
  • 11.16.4 Business Strategy
  • 11.16.5 SWOT Analysis
  • 11.16.6 Strategic Implications (2026–2032)
  • 11.17 Biontex Laboratories GmbH
  • 11.17.1 Company Overview
  • 11.17.2 Key Products & Segments
  • 11.17.3 Financial Performance (2023–2025)
  • 11.17.4 Business Strategy
  • 11.17.5 SWOT Analysis
  • 11.17.6 Strategic Implications (2026–2032)
  • 11.18 Celetrix LLC
  • 11.18.1 Company Overview
  • 11.18.2 Key Products & Segments
  • 11.18.3 Financial Performance (2023–2025)
  • 11.18.4 Business Strategy
  • 11.18.5 SWOT Analysis
  • 11.18.6 Strategic Implications (2026–2032)
12Competitive Landscape
  • 12.1 Competitive Landscape Overview
  • 12.2 Competitive Intensity Assessment
  • 12.3 Key Player Strategies & Positioning
  • 12.4 Competitive Dynamics & Strategic Outlook
  • 12.4.1 Emerging Competitive Threats
  • 12.4.2 Consolidation vs. Fragmentation Outlook
  • 12.4.3 Competitive Response Matrix
  • 12.4.4 Strategic Recommendations, 2026–2032
13Porter's Five Forces Analysis
  • 13.1 Threat of New Entrants
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Threat of Substitutes
  • 13.5 Competitive Rivalry
14PESTLE Analysis
  • 14.1 Political
  • 14.2 Economic
  • 14.3 Social and Demographic
  • 14.4 Technological
  • 14.5 Legal and Regulatory
  • 14.6 Environmental
  • 14.7 Strategic Implications of the PESTLE Assessment
15SWOT Analysis
16Future Trends & Outlook
  • 16.1 Future Trends & Outlook
  • 16.1.1 Trend Summary and Commercial Maturity Assessment
  • 16.1.2 Technology and Innovation Trends
  • 16.1.3 Long-Term Market Outlook
  • 16.1.4 Investment & M&A Activity Outlook
  • 16.1.5 Overall Outlook Assessment

Frequently asked questions

Which regions and countries are covered for Transfection Reagents and Equipment?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the main segments of the Transfection Reagents and Equipment market?
The market is segmented by Product (Reagents and Equipment), Method (Biochemical Methods, Physical Methods and Viral Methods), Application (Protein Production, Gene & mRNA Expression Studies, Cell & Gene Therapy Manufacturing, Cancer Research and Drug Discovery & Screening), Cell Type (Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells and Plant Cells) and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROs & CMOs), with forecasts for each segment.
Who are the key players in the Transfection Reagents and Equipment market?
Key players profiled include Thermo Fisher Scientific, Lonza Group, Merck KGaA (Millipore Sigma), Bio-Rad Laboratories, Qiagen N.V., MaxCyte, Mirus Bio, Polyplus-transfection SA, Promega Corporation, Agilent Technologies and 8 more, among 18 companies covered in total.
Who should buy the Transfection Reagents and Equipment market report?
The report is intended for manufacturers and solution providers, distributors and end users, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Transfection Reagents and Equipment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
PURCHASE THIS REPORT
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.